Gradient Ventures backs BenchSci
Gradient Ventures has made an additional investment in BenchSci, bringing the latter company's total funding to $20.5 million. Based in Toronto, BenchSci is an AI-assisted antibody selection platform.
25 June 2019•1 min read
